Evaluating the Risk of Hypophosphatemia with Ferric Carboxymaltose and the Recommended Approaches for Management: A Consensus Statement

Rosano G, Ezekowitz J, Nemeth E, Ponikowski P, Rauner M, Seid M, Spahn DR, Stein J, Wish J, Mentz RJ. Evaluating the Risk of Hypophosphatemia with Ferric Carboxymaltose and the Recommended Approaches for Management: A Consensus Statement. J Clin Med. 2025 Jul 9;14(14):4861. doi: 10.3390/jcm14144861. PMID: 40725553.


Related Posts